Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study.

Gustafsson I, Hvelplund A, Hansen KW, Galatius S, Madsen M, Jensen JS, Tilsted HH, Terkelsen CJ, Jensen LO, Jørgensen E, Madsen JK, Abildstrøm SZ.

Open Heart. 2015 Feb 6;2(1):e000165. doi: 10.1136/openhrt-2014-000165. eCollection 2015.

2.

The Western Denmark Cardiac Computed Tomography Registry: a review and validation study.

Nielsen LH, Nørgaard BL, Tilsted HH, Sand NP, Jensen JM, Bøttcher M, Diederichsen AC, Lambrechtsen J, Kristensen LD, Mickley H, Munkholm H, Gøtzsche O, Knudsen LL, Bøtker HE, Pedersen L, Schmidt M.

Clin Epidemiol. 2014 Dec 31;7:53-64. doi: 10.2147/CLEP.S73728. eCollection 2015. Review.

3.

10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25875. [Epub ahead of print]

PMID:
25640050
4.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; for the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Jan 16. pii: S0140-6736(14)61794-3. doi: 10.1016/S0140-6736(14)61794-3. [Epub ahead of print]

PMID:
25601789
5.

Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.

Jabbari R, Engstrøm T, Glinge C, Risgaard B, Jabbari J, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Chiuve SE, Pedersen F, Svendsen JH, Haunsø S, Albert CM, Tfelt-Hansen J.

J Am Heart Assoc. 2015 Jan 5;4(1):e001399. doi: 10.1161/JAHA.114.001399.

6.

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.

PMID:
25499925
7.

Coronary computed tomography angiography without significant stenosis predicts favourable three-year prognosis.

Kristiansen JM, Zaremba T, Johansen MB, Tilsted HH, Jensen SE.

Dan Med J. 2014 Aug;61(8):A4884.

PMID:
25162443
8.

Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.

9.

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30.

PMID:
25086842
10.

24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.

Würtz M, Hvas AM, Jensen LO, Kaltoft AK, Tilsted HH, Kristensen SD, Grove EL.

Int J Cardiol. 2014 Aug 1;175(2):274-9. doi: 10.1016/j.ijcard.2014.05.013. Epub 2014 May 16.

PMID:
24861258
11.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-56. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

PMID:
24631162
12.

Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.

Hougaard M, Thayssen P, Kaltoft A, Tilsted HH, Maeng M, Lassen JF, Thuesen L, Okkels Jensen L.

Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1035-42. doi: 10.1002/ccd.25279. Epub 2013 Dec 5.

PMID:
24311384
13.

Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology.

Thuesen L, Jensen LO, Tilsted HH, Mæng M, Terkelsen C, Thayssen P, Ravkilde J, Christiansen EH, Bøtker HE, Madsen M, Lassen JF.

Clin Epidemiol. 2013 Sep 19;5:357-61. doi: 10.2147/CLEP.S44651. eCollection 2013.

14.

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.

Antonsen L, Thayssen P, Hansen HS, Maeng M, Tilsted HH, Bøtker HE, Ravkilde J, Madsen M, Sørensen HT, Thuesen L, Lassen JF, Jensen LO.

EuroIntervention. 2014 Jun;10(2):212-23. doi: 10.4244/EIJV10I2A35.

15.

Employment status 1 year after out-of-hospital cardiac arrest in comatose patients treated with therapeutic hypothermia.

Kragholm K, Skovmoeller M, Christensen AL, Fonager K, Tilsted HH, Kirkegaard H, DE Haas I, Rasmussen BS.

Acta Anaesthesiol Scand. 2013 Aug;57(7):936-43. doi: 10.1111/aas.12142. Epub 2013 Jun 10.

PMID:
23750664
16.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

17.

[No need for decentralized PCI now].

Tilsted HH.

Ugeskr Laeger. 2013 Feb 4;175(6):378-9. Danish. No abstract available.

PMID:
23530281
18.

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.

Kelbæk H, Engstrøm T, Ahtarovski KA, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted HH, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L.

EuroIntervention. 2013 Feb 22;8(10):1126-33. doi: 10.4244/EIJV8I10A175.

19.

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

Christiansen EH, Jensen LO, Thayssen P, Tilsted HH, Krusell LR, Hansen KN, Kaltoft A, Maeng M, Kristensen SD, Bøtker HE, Terkelsen CJ, Villadsen AB, Ravkilde J, Aarøe J, Madsen M, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) V investigators.

Lancet. 2013 Feb 23;381(9867):661-9. doi: 10.1016/S0140-6736(12)61962-X. Epub 2013 Jan 30. Erratum in: Lancet. 2013 Jul 27;382(9889):310. Noergaard, Bjarne Linde [corrected to Norgaard, Bjarne Linde].

PMID:
23374649
20.

Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease.

Azimi A, Charlot MG, Torp-Pedersen C, Gislason GH, Køber L, Jensen LO, Thayssen P, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L.

Heart. 2013 May;99(9):655-60. doi: 10.1136/heartjnl-2012-303066. Epub 2013 Jan 18.

PMID:
23335496
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk